In addition, several novel biomarkers including Prostate Health Index (PHI), Prostate Cancer Antigen 3 (PCA3), 4K Score, and a number of non-coding RNAs have been reported in improving the diagnosis accuracy of PCa, especially at initial biopsy (27–30), but most of them are not widely used at present. Here, PCA3 is linked to posterior cortical atrophy.